About
First-in-class dual inhibitor of ataxia-telangiectasia mutated and DNA-dependent protein kinase
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Funding History (1)
D
Dec 19, 2017
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...